Veloxis Restructures to Focus on Late-Stage Once-Daily Immunosuppressant - Genetic Engineering News

Apart from LCP-Tacro, the firm’s clinical pipeline includes the Phase II- and III-ready cardiovascular products AtorFen™, a fixed-dose combination tablet of fenofibrate and atorvastatin, and LCP-Feno™, a generic fenofibrate tablet formulation.

Expect strong growth from US in FY13-14: Lupin - MoneyControl.com

A: Firstly on Antara, the fenofibrate market in America was declining. To that extent, Antara also saw a decline. But the decline was itself much lower than the market decline in Fenofibrate as a category. When it comes to the direct-to-market ...

Abbott: New Reasons The Split Could Tank Stock - Seekingalpha.com

Fenofibrate, sold as Trilipix and Tricor, is the next biggest product, with sales of $329 million, but sales have fallen by 11%, year over year. Androgel is the newest high flyer, with "low-T" being the latest over-hyped bugaboo to bedevil aging baby boomers.

Santarus Announces Presentation of UCERIS Phase III Extended Use Data at Digestive Disease Week Meeting - Marketwatch

(fenofibrate) tablets, which is indicated as an adjunct to diet to reduce high cholesterol. Santarus has a diverse product development pipeline. A New Drug Application for UCERIS(TM) (budesonide) 9 mg tablets for induction of remission of mild ...

Buy Lupin; target Rs 633: Nirmal Bang - MoneyControl.com

Adjusting for this, the tax rate stood at 26%. 1) In the branded generic segment, Suprax franchise recorded 30% growth, while Antara’s growth declined 6% against an 18% fall in the fenofibrate market. Prescription share in Antara increased to ...

Santarus Reports First Quarter 2012 Financial Results - Marketwatch

FENOGLIDE(fenofibrate) tablets new prescriptions grew 17% and total prescriptions increased 11% for the four-week period ending April 20, 2012, compared with the four-week period ending February 3, 2012, which was just prior to Santarus ...

Santarus' CEO Presents at Bank of America Merrill Lynch 2012 Health Care Conference (Transcript) - Seekingalpha.com

This is of course fenofibrate, it’s a low dose version of fenofibrate and of course indicated for the treatment of hypertriglyceridemia as well as mixed dyslipidemia. And you are well aware, the high overlap of co-morbidity and obesity and cardiovascular ...